Anatomically realistic nasal replicas capturing the range of nasal spray drug delivery in adults

被引:11
|
作者
Alfaifi, Ali [1 ]
Hosseini, Sana [1 ]
Esmaeili, Amir R. [1 ]
Walenga, Ross [2 ]
Babiskin, Andrew [2 ]
Schuman, Theodore [3 ]
Longest, Worth [1 ,4 ]
Hindle, Michael [4 ]
Golshahi, Laleh [1 ]
机构
[1] Virginia Commonwealth Univ, Dept Mech & Nucl Engn, Richmond, VA 23284 USA
[2] US FDA, Ctr Drug Evaluat & Res, Div Quantitat Methods & Modeling, Off Res & Stand, Silver Spring, MD USA
[3] VCU Hlth, Dept Otolaryngol Head & Neck Surg, Richmond, VA USA
[4] Virginia Commonwealth Univ, Dept Pharmaceut, Richmond, VA USA
关键词
Nasal spray; Regional deposition; Anatomical variability; Bioequivalence; Locally-acting drugs; In vitro aerosol testing; DEPOSITION; PHYSIOLOGY; ANATOMY; NOSE; VARIABILITY; PARTICLES; PATTERNS; PUMPS;
D O I
10.1016/j.ijpharm.2022.121858
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
To improve the relationships between commonly conducted in vitro studies for locally-acting nasal spray drug products with in vivo regional deposition, this study developed a set of in vitro adult nasal geometries that captured the range of nasal drug delivery to the region posterior to internal nasal valve (INV), also known as posterior delivery (PD), and evaluated their performance with existing in vivo data. The PD of fluticasone propionate (FP) and fluticasone furoate (FF) in 40 nasal cavities was statistically analyzed to identify three airway models representing the low, mean, and high PD in adults. The models were also externally validated by comparing the in vitro nasal deposition from a different drug product (mometasone furoate (MF)) with the relevant in vivo data. The three selected geometries represented the low, mean, and high PD with multiple nasal sprays. They were verified in terms of reproducibility of in vitro data and validated by showing a reasonable agreement with preexisting in vivo MF PD despite differences in administration and defining the regions. The three models are envisioned to potentially facilitate the development of locally-acting nasal sprays and provide a better understanding of how in vitro metrics relate to in vivo regional nasal deposition.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] PLGA nanoparticles for nasal drug delivery
    Alghareeb, Salah
    Asare-Addo, Kofi
    Conway, Barbara R.
    Adebisi, Adeola O.
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2024, 95
  • [32] Further developments in nasal drug delivery
    Davis, SS
    PHARMACEUTICAL SCIENCE & TECHNOLOGY TODAY, 1999, 2 (07): : 265 - 266
  • [33] Advances in Respiratory and Nasal Drug Delivery
    Lechuga-Ballesteros, David
    Miller, Danforth P.
    MOLECULAR PHARMACEUTICS, 2015, 12 (08) : 2561 - 2561
  • [34] Progress in nasal drug delivery systems
    Laffleur, Flavia
    Bauer, Bettina
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2021, 607
  • [35] Microspheres as nasal drug delivery systems
    Pereswetoff-Morath, L
    ADVANCED DRUG DELIVERY REVIEWS, 1998, 29 (1-2) : 185 - 194
  • [36] Biopolymers as Carriers for Nasal Drug Delivery
    Brar, Vivekjot
    Kaur, Gurpreet
    POLYMER-PLASTICS TECHNOLOGY AND ENGINEERING, 2014, 53 (14) : 1518 - 1531
  • [37] Nasal route and drug delivery systems
    Selcan Türker
    Erten Onur
    Yekta Ózer
    Pharmacy World and Science, 2004, 26 : 137 - 142
  • [38] Nasal route and drug delivery systems
    Türker, S
    Onur, E
    Özer, Y
    PHARMACY WORLD & SCIENCE, 2004, 26 (03): : 137 - 142
  • [39] Smart Polymers in Nasal Drug Delivery
    Chonkar, Ankita
    Nayak, Usha
    Udupa, N.
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 77 (04) : 367 - 375
  • [40] Chitosan nanoparticles for nasal drug delivery
    Alghareeb, Salah
    Ekenna, Ifeoma
    Asare-Addo, Kofi
    Conway, Barbara R.
    Adebisi, Adeola O.
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2025, 105